Curanex Pharmaceuticals Inc
CURX
$0.31
$0.000.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,920.41% | 3,239.89% | 2,286.61% | -70.91% | 167.34% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 64,584.13% | 521,100.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 104.11% | -- |
| Total Current Assets | 1,062.72% | 2,067.89% | 2,423.24% | 6.74% | -- |
|
|
|||||
| Total Current Assets | 1,062.72% | 2,067.89% | 2,423.24% | 6.74% | -- |
| Net Property, Plant & Equipment | 249.39% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 968.92% | 2,135.97% | 2,140.86% | 9.97% | -- |
|
|
|||||
| Total Accounts Payable | -93.34% | -52.00% | -- | -- | -- |
| Total Accrued Expenses | 238.46% | 23.96% | 83.93% | 733.33% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 71.09% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -33.18% | 838.36% | 3,221.43% | 12,550.00% | -- |
|
|
|||||
| Total Current Liabilities | -33.18% | 838.36% | 3,221.43% | 12,550.00% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 612.94% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -21.04% | 2,372.60% | 3,221.43% | 80,183.33% | -- |
|
|
|||||
| Common Stock & APIC | 1,636.66% | 1,635.61% | 1,635.61% | 2.80% | -- |
| Retained Earnings | -952.34% | -678.86% | -265.63% | -112.92% | -- |
| Treasury Stock & Other | -- | -- | -- | 0.00% | -- |
| Total Common Equity | 2,109.05% | 2,129.09% | 2,131.75% | -57.31% | 508.49% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | 2,109.05% | 2,129.09% | 2,131.75% | -57.31% | 508.49% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2,108.47% | 2,128.67% | 2,131.41% | -57.30% | 508.65% |
|
|
|||||